Testosterone drugs under FDA review for heart-attack risk
Testosterone drugs, which make up a growing market for pharmaceutical companies such as Eli Lilly, are getting a closer look from U.S. regulators.
Bloomberg News
Articles
Simon purchases Long Island land from rival Taubman
Simon also purchased the company’s 50-percent stake in Arizona Mills Taubman received $230 million in Simon Property shares and $60 million in cash for the two transactions.
Lilly tops estimates despite shrinking Cymbalta sales
The Indianapolis drugmaker said gains in other products offset declines for its top drug Cymbalta, which lost patent protection in December. Overall, sales slipped 2 percent, to $5.8 billion.
ITT stock sinks as for-profit colleges face more probes
For-profit colleges, bruised by years of investigations and rule-making, may face additional financial pressure from a new wave of state probes by attorneys general and the U.S. Consumer Financial Protection Bureau.
Workers not owed for changing time, Supreme Court rules
Companies in many cases don’t have to pay workers for the time they spend putting on and taking off safety gear, the U.S. Supreme Court ruled, siding with U.S. Steel Corp. in a lawsuit by 800 workers.
Benchmark stock indexes suffer worst week since 2012
The Standard & Poor’s 500 index retreated 2.1 percent Friday, to 1,790.31, to close at its lowest level since Dec. 17. The benchmark index declined 2.6 percent this week. The Dow Jones industrial average lost 3.5 percent this week.
Toyota, Honda set North American production records
Toyota built 1.86 million cars and light trucks at U.S., Canadian and Mexican plants in 2013, while Tokyo-based Honda made 1.78 million autos in North America.
NiSource’s pipelines make it a prime takeover target
NiSource, which operates the largest natural gas distribution company and second largest electric distribution company in the state, could be acquired by a company seeking to profit from the shale-gas boom.
Obamacare small-biz plan lags as employers stand pat
Greeted by higher premiums, less generous coverage and more paperwork, small businesses are choosing to renew existing health plans rather than buy them through President Barack Obama’s program.
Indiana joins Feds in reviewing merger of Sysco, US Foods
Sysco, with annual revenue of about $44 billion, is the top operator in the U.S. food distribution business. Adding No. 2 US Foods would create a corporation in charge of at least a quarter of the North American market.
Five questions: Indiana treasurer ponders course for yield rise
Richard Mourdock, a 62-year-old geologist and former coal-mining exec in his second term as Indiana treasurer, discusses his approach to managing $7 billion in state funds.
Man charged with trying to send Iran fighter-jet documents
Mozaffar Khazaee, a native of Iran who became a naturalized U.S. citizen in 1991 and recently moved to Indianapolis, was arrested before he was able to board a connecting flight to Frankfurt.
Indiana considers amendment that could shield industrial farms
The bill’s sponsors say it’s a way to keep non-farmers, including national animal rights groups, from meddling in the state’s rural interests.
Corn pile biggest since 1994 as crop overwhelms use
Stockpiles of corn in the United States, the world’s top grower, are rising at the fastest pace in 19 years as a record crop overwhelms increased demand for the grain used to make livestock feed and ethanol.
Group led by WellPoint to partner on global health network
The Blue Cross and Blue Shield Association will form a combined provider network with London-based Bupa that will collectively include more than 11,500 hospitals in more than 190 countries, the partners said Thursday.
WellPoint seeks more Obamacare biz by extending deadline
Two of the largest U.S. health insurers are giving Obamacare customers more time to pay their initial premiums as the industry tries to coax millions of people to take the final step in cementing coverage for 2014.
WellPoint to unload 1-800-Contacts unit
Financial terms of the sale to Boston-based private equity firm Thomas H. Lee Partners LP weren’t disclosed. WellPoint paid a reported $900 million to buy the company in June 2012.
Lilly forecasts sales, profit drop in face of rival generic drugs
In a warning shot to investors, the pharmaceutical giant says it expects “2014 to be the most financially challenging year of Lilly’s current period of patent expirations.”
Bengals join Packers, Colts with sellout preventing blackouts
All four of the National Football League’s wild-card playoff games will be televised in their host team’s local market after corporate support helped ensure sellouts.
Feds extend Obamacare deadline as customers rush site
The deadline to enroll in plans that begin Jan. 1 now is midnight Tuesday for most of the U.S. On Monday, healthcare.gov fielded nearly 50,000 simultaneous visitors, triggering a queuing system.